Exocrine Pancreatic Insufficiency Market - Global Outlook and Forecast 2021-2027

Code: RW00014576034
Market Monitor Global
Oct-2021
Life Sciences
92 Pages

This report contains market size and forecasts of Exocrine Pancreatic Insufficiency in Global, including the following market information:
Global Exocrine Pancreatic Insufficiency Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Exocrine Pancreatic Insufficiency market was valued at 2073.7 million in 2020 and is projected to reach US$ 2402.2 million by 2027, at a CAGR of 3.7% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Exocrine Pancreatic Insufficiency companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Exocrine Pancreatic Insufficiency Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Exocrine Pancreatic Insufficiency Market Segment Percentages, By Type, 2020 (%)
Therapeutics
Diagnostics

China Exocrine Pancreatic Insufficiency Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Exocrine Pancreatic Insufficiency Market Segment Percentages, By Application, 2020 (%)
Hospitals
Clinics
Others

Global Exocrine Pancreatic Insufficiency Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Exocrine Pancreatic Insufficiency Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Exocrine Pancreatic Insufficiency Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Exocrine Pancreatic Insufficiency Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Axcan Pharma
Aptalis Pharma
Eli Lilly
Cilian
Nordmark Arzneimittel
Laboratoires Mayoly Spindler

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Exocrine Pancreatic Insufficiency Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Exocrine Pancreatic Insufficiency Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Exocrine Pancreatic Insufficiency Overall Market Size
2.1 Global Exocrine Pancreatic Insufficiency Market Size: 2021 VS 2027
2.2 Global Exocrine Pancreatic Insufficiency Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Exocrine Pancreatic Insufficiency Players in Global Market
3.2 Top Global Exocrine Pancreatic Insufficiency Companies Ranked by Revenue
3.3 Global Exocrine Pancreatic Insufficiency Revenue by Companies
3.4 Top 3 and Top 5 Exocrine Pancreatic Insufficiency Companies in Global Market, by Revenue in 2020
3.5 Global Companies Exocrine Pancreatic Insufficiency Product Type
3.6 Tier 1, Tier 2 and Tier 3 Exocrine Pancreatic Insufficiency Players in Global Market
3.6.1 List of Global Tier 1 Exocrine Pancreatic Insufficiency Companies
3.6.2 List of Global Tier 2 and Tier 3 Exocrine Pancreatic Insufficiency Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Exocrine Pancreatic Insufficiency Market Size Markets, 2021 & 2027
4.1.2 Therapeutics
4.1.3 Diagnostics
4.2 By Type - Global Exocrine Pancreatic Insufficiency Revenue & Forecasts
4.2.1 By Type - Global Exocrine Pancreatic Insufficiency Revenue, 2016-2021
4.2.2 By Type - Global Exocrine Pancreatic Insufficiency Revenue, 2022-2027
4.2.3 By Type - Global Exocrine Pancreatic Insufficiency Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Exocrine Pancreatic Insufficiency Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Exocrine Pancreatic Insufficiency Revenue & Forecasts
5.2.1 By Application - Global Exocrine Pancreatic Insufficiency Revenue, 2016-2021
5.2.2 By Application - Global Exocrine Pancreatic Insufficiency Revenue, 2022-2027
5.2.3 By Application - Global Exocrine Pancreatic Insufficiency Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Exocrine Pancreatic Insufficiency Market Size, 2021 & 2027
6.2 By Region - Global Exocrine Pancreatic Insufficiency Revenue & Forecasts
6.2.1 By Region - Global Exocrine Pancreatic Insufficiency Revenue, 2016-2021
6.2.2 By Region - Global Exocrine Pancreatic Insufficiency Revenue, 2022-2027
6.2.3 By Region - Global Exocrine Pancreatic Insufficiency Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Exocrine Pancreatic Insufficiency Revenue, 2016-2027
6.3.2 US Exocrine Pancreatic Insufficiency Market Size, 2016-2027
6.3.3 Canada Exocrine Pancreatic Insufficiency Market Size, 2016-2027
6.3.4 Mexico Exocrine Pancreatic Insufficiency Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Exocrine Pancreatic Insufficiency Revenue, 2016-2027
6.4.2 Germany Exocrine Pancreatic Insufficiency Market Size, 2016-2027
6.4.3 France Exocrine Pancreatic Insufficiency Market Size, 2016-2027
6.4.4 U.K. Exocrine Pancreatic Insufficiency Market Size, 2016-2027
6.4.5 Italy Exocrine Pancreatic Insufficiency Market Size, 2016-2027
6.4.6 Russia Exocrine Pancreatic Insufficiency Market Size, 2016-2027
6.4.7 Nordic Countries Exocrine Pancreatic Insufficiency Market Size, 2016-2027
6.4.8 Benelux Exocrine Pancreatic Insufficiency Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Exocrine Pancreatic Insufficiency Revenue, 2016-2027
6.5.2 China Exocrine Pancreatic Insufficiency Market Size, 2016-2027
6.5.3 Japan Exocrine Pancreatic Insufficiency Market Size, 2016-2027
6.5.4 South Korea Exocrine Pancreatic Insufficiency Market Size, 2016-2027
6.5.5 Southeast Asia Exocrine Pancreatic Insufficiency Market Size, 2016-2027
6.5.6 India Exocrine Pancreatic Insufficiency Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Exocrine Pancreatic Insufficiency Revenue, 2016-2027
6.6.2 Brazil Exocrine Pancreatic Insufficiency Market Size, 2016-2027
6.6.3 Argentina Exocrine Pancreatic Insufficiency Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Exocrine Pancreatic Insufficiency Revenue, 2016-2027
6.7.2 Turkey Exocrine Pancreatic Insufficiency Market Size, 2016-2027
6.7.3 Israel Exocrine Pancreatic Insufficiency Market Size, 2016-2027
6.7.4 Saudi Arabia Exocrine Pancreatic Insufficiency Market Size, 2016-2027
6.7.5 UAE Exocrine Pancreatic Insufficiency Market Size, 2016-2027
7 Players Profiles
7.1 Axcan Pharma
7.1.1 Axcan Pharma Corporate Summary
7.1.2 Axcan Pharma Business Overview
7.1.3 Axcan Pharma Exocrine Pancreatic Insufficiency Major Product Offerings
7.1.4 Axcan Pharma Exocrine Pancreatic Insufficiency Revenue in Global (2016-2021)
7.1.5 Axcan Pharma Key News
7.2 Aptalis Pharma
7.2.1 Aptalis Pharma Corporate Summary
7.2.2 Aptalis Pharma Business Overview
7.2.3 Aptalis Pharma Exocrine Pancreatic Insufficiency Major Product Offerings
7.2.4 Aptalis Pharma Exocrine Pancreatic Insufficiency Revenue in Global (2016-2021)
7.2.5 Aptalis Pharma Key News
7.3 Eli Lilly
7.3.1 Eli Lilly Corporate Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Exocrine Pancreatic Insufficiency Major Product Offerings
7.3.4 Eli Lilly Exocrine Pancreatic Insufficiency Revenue in Global (2016-2021)
7.3.5 Eli Lilly Key News
7.4 Cilian
7.4.1 Cilian Corporate Summary
7.4.2 Cilian Business Overview
7.4.3 Cilian Exocrine Pancreatic Insufficiency Major Product Offerings
7.4.4 Cilian Exocrine Pancreatic Insufficiency Revenue in Global (2016-2021)
7.4.5 Cilian Key News
7.5 Nordmark Arzneimittel
7.5.1 Nordmark Arzneimittel Corporate Summary
7.5.2 Nordmark Arzneimittel Business Overview
7.5.3 Nordmark Arzneimittel Exocrine Pancreatic Insufficiency Major Product Offerings
7.5.4 Nordmark Arzneimittel Exocrine Pancreatic Insufficiency Revenue in Global (2016-2021)
7.5.5 Nordmark Arzneimittel Key News
7.6 Laboratoires Mayoly Spindler
7.6.1 Laboratoires Mayoly Spindler Corporate Summary
7.6.2 Laboratoires Mayoly Spindler Business Overview
7.6.3 Laboratoires Mayoly Spindler Exocrine Pancreatic Insufficiency Major Product Offerings
7.6.4 Laboratoires Mayoly Spindler Exocrine Pancreatic Insufficiency Revenue in Global (2016-2021)
7.6.5 Laboratoires Mayoly Spindler Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Exocrine Pancreatic Insufficiency Market Opportunities & Trends in Global Market
Table 2. Exocrine Pancreatic Insufficiency Market Drivers in Global Market
Table 3. Exocrine Pancreatic Insufficiency Market Restraints in Global Market
Table 4. Key Players of Exocrine Pancreatic Insufficiency in Global Market
Table 5. Top Exocrine Pancreatic Insufficiency Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Exocrine Pancreatic Insufficiency Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Exocrine Pancreatic Insufficiency Revenue Share by Companies, 2016-2021
Table 8. Global Companies Exocrine Pancreatic Insufficiency Product Type
Table 9. List of Global Tier 1 Exocrine Pancreatic Insufficiency Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Exocrine Pancreatic Insufficiency Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE